Biotech Companies are Expanding in Delaware

Two companies are growing in Delaware, which will result in the creation of several dozen new jobs in the state. The Delaware Prosperity Partnership announced Monday, August 9, 2021 that Advanced Materials Technology (AMT) in Talleyville and Sepax Technologies in Newark will expand their businesses in exchange for state grants. Within three years, AMT will nearly double its current employment of 39 employees, hiring 35 new employees.

The biopharmaceutical company is a pioneer in the field of high-performance liquid chromatography, having developed the first small-particle core-shell packing material. In addition to the 17,000 square feet already leased, the company will lease an additional 12,380 square feet. ft. at Concord Plaza, which it already leases, to expand its research & development and manufacturing operations.

Governor John Carney said, “We are pleased that AMT will be expanding their operations here in Delaware. As we continue to rebuild our economy, we should do everything we can to support innovation and good-paying jobs.” AMT will invest $4.5 million in its expansion, including $3 million to refurbish lab space to accommodate the company’s development. In exchange, the state will provide the corporation with a $89,705 jobs performance grant and a $619,000 lab space grant.

Tim Langloiss, co-founder and president of Advanced Materials Technology, said the awards were the deciding factor in the company’s decision to stay in Delaware. Sepax Technologies, a biotechnology firm formed in 2002 by a University of Delaware alum, has pledged to hire 35 new full-time employees by the end of 2023. It now employs 55 full-time employees. For more than 3,000 customers throughout the world, the company manufactures liquid chromatography, including bulk resins.